InvestorsHub Logo
icon url

BTH

10/06/12 10:31 AM

#22825 RE: biotech_researcher #22821

Ibrutinib and 113 are two entirely different classes of drug in separate indications and markets.

But 113 is very probable, a billion dollar drug; even though its early.